Hanx Biopharma begins patient dosing in Australia for phase 1 trial of HX044 to treat advanced solid tumours: Wuhan, China Saturday, January 4, 2025, 16:00 Hrs [IST] Hanx Biopharm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback